Product News
Filter News
Found 185,986 articles
-
Ahead of being absorbed by Bristol-Myers Squibb, Celgene forged a strategic collaboration with two companies to develop immuno-oncology treatments and cell therapies.
-
Eli Lilly’s ANNOUNCE Phase III clinical trial of Lartruvo (olaratumab) in advanced or metastatic soft tissue sarcoma failed to meet the primary endpoints of overall survival.
-
Yesterday, the Endocrinologic and Metabolic Drugs Advisory Committee had a split vote, 8 to 8, on whether the overall benefits of Zynquista (sotagliflozin) outweiged the risk in order to support approval. This sends things back to the agency to make a final decision, which has a target action dat...
-
Immunomedics was hoping for a green light from the U.S. Food and Drug Administration for its triple-negative breast cancer treatment, sacituzumab govitecan. However, this morning the company announced that approval will not likely be coming any time soon.
-
The rate of incidence of infection by Naegleria fowleri in the U.S. is very, very low. But there’s something about picking up an incurable, brain-eating amoeba by swimming in freshwater lakes and rivers that understandably freaks people out.
-
The two companies inked a non-disclosure agreement on December 22, 2018 and amended it a day later. One of the things apparent is that the companies wanted to make a splash at the JPM conference.
-
Janssen Pharmaceuticals and Apple have teamed up to determine if a new app for the Apple Watch, which has a built-in electrocardiogram can improve the health of more than 30 million people with atrial fibrillation (AFib), a condition that can lead to stroke and other potentially devastating compl...
-
Novartis and Oxford will use artificial intelligence and advanced analytics to identify early predictors of inflammatory diseases.
-
Kura Oncology Reports Clinical Activity of Tipifarnib in Subsets of Pancreatic Cancer Associated with High CXCL12 Expression
1/18/2019
Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, reported new findings identifying a potential association between CXCL12 expression and clinical benefit in patients with pancreatic cancer treated with tipifarnib.
-
Cannabis Company Starling Brands, Inc. Announces Global Licensing Partnership with Pioneering CBD Brand, Jayden's Juice
1/18/2019
Starling Brands is pleased to announce the expansion of their global licensing, manufacturing and distribution deal with world-renowned brand Jayden's Juice, one of the pioneers in the cannabis CBD movement.
-
Bayer introduces versatile new option for heartworm prevention and intestinal parasite control
1/18/2019
Bayer Animal Health announces the launch of Coraxis™ (moxidectin) Topical Solution for Dogs, a prescription-only, monthly transdermal product that prevents heartworm disease and treats and controls hookworms, roundworms, and whipworms in dogs.
-
Navitus Launches a New Website and Refreshed Brand to Further Its Mission to Make Prescription Benefits More Affordable
1/18/2019
Navitus Health Solutions, a full-service prescription benefit manager (PBM), is pleased to announce the launch of its new website and refreshed brand at www.navitus.com.
-
BoneSmart® to host 2nd Joint Replacement Awareness Day® on May 4, 2019
1/18/2019
Over 1 million total hip and total knee replacement procedures are performed each year in the United States1.
-
New Online Resource from AGA and the IBD Parenthood Project, in Collaboration with Multidisciplinary Experts, Provides Guidance and Dispels Fears About Pregnancy for Women with IBD
1/18/2019
Downloadable toolkit educates around the proper planning and care required for healthy pregnancies and healthy babies
-
ImaginAb Enrolls First Patient in Phase II Clinical Trial
1/18/2019
ImaginAb, Inc., an emerging immuno-oncology imaging company, announced the enrollment of the first patient in the Phase II clinical trial of ImaginAb's CD8+ T Cell imaging agent.
-
Teleflex to Showcase the MANTA™ Vascular Closure Device from the Recently Acquired Essential Medical, Inc. at the Annual Meeting of the Leipzig Interventional Course (LINC) 2019, in Leipzig, Germany, on January 22-25
1/18/2019
Teleflex Incorporated surgical and cardiac care, will showcase the MANTA™ Vascular Closure Device as well as its portfolio for peripheral interventions at the Annual Meeting of the Leipzig Interventional Course (LINC) 2019, in Leipzig, Germany.
-
Plant Nanny2 Helps Users Keep Hydrated This New Year With Updated App
1/18/2019
Fourdesire, an innovative mobile design studio, today announced the launch of the second version of their popular mobile app, Plant Nanny.
-
CVS Health and Walmart Announce New PBM Pharmacy Network Agreement
1/18/2019
Walmart to Continue Participating in CVS Caremark Commercial and Managed Medicaid Retail Pharmacy Networks
-
Lilly Reports Results of Phase 3 Soft Tissue Sarcoma Study of LARTRUVO®
1/18/2019
Study did not meet the primary endpoints of overall survival (OS) in the full study population or in the leiomyosarcoma (LMS) sub-population; there was no difference in survival between the study arms for either population.
-
Alternate Health Secures Second Set of Licenses for Cannabis Manufacturing and Distribution in Los Angeles
1/18/2019
Alternate Health Corp., ("Alternate Health" or the "Company") (CSE:AHG) (OTCQB:AHGIF), an international leader in technology solutions for the regulated cannabis industry, announced today that that Company has secured state licenses for the manufacturing and distribution of cannabis at its facility in Los Angeles, California in addition to its licenses in Humboldt County, California.